Multi-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCL
Clinical trial NCT07724782 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07724782
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-07-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.